Imugene Limited (ASX:IMU) Receives $5.8m R&D Tax Refund
Imugene Limited (ASX:IMU) receives a A$5.8m R&D tax refund to advance its immuno-oncology pipeline.
Imugene Limited (ASX:IMU) receives a A$5.8m R&D tax refund to advance its immuno-oncology pipeline.
Magellan Financial Group (ASX:MFG) reports AUM of $39.6 billion, net outflows of $0.2 billion in June, and a shift to quarterly AUM reporting.
Tourism Holdings Limited (ASX:THL) updates its FY25 profit guidance, addressing challenges in global RV sales and outlining a positive outlook for FY26.
PlaySide Studios (ASX:PLY) reports MOUSE: P.I. For Hire surpassing 1 million wishlists on Steam, indicating strong anticipation for its 2025 launch.
Prospech Limited (ASX:PRS) initiates metallurgical testing on a 500kg REE bulk sample for the Korsnäs project in Finland and Australia.
Resolution Minerals (ASX:RML) launches its maiden exploration program at the Horse Heaven Project, aiming to expand its antimony and gold resources in Idaho.
Pro Medicus Limited (ASX:PME) signs a A$170M, 10-year contract with UCHealth to implement its Visage 7 imaging platform.
Invictus Energy Ltd (ASX:IVZ) announces progress on PPSA and National Project Status for Cabora Bassa Project in Zimbabwe.
NeuroScientific Biopharmaceuticals Ltd (ASX:NSB) completes acquisition of StemSmart technology, appoints new directors, and launches clinical program for Crohn’s disease treatment.
Manuka Resources (ASX:MKR) announces financing discussions and updates its silver & gold production strategy for the Cobar Basin.